Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.
Relay Therapeutics has raised $275.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in May 2026.
Relay Therapeutics's investors include Perceptive Advisors, Foresite Capital, Third Rock Ventures, Google Ventures, S32.
Relay Therapeutics is headquartered in Cambridge, United States.
Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.
Relay Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Relay Therapeutics — Funding & Investors." VCBacked, May 20, 2026, https://www.vcbacked.co/company/relay-therapeutics. Accessed July 19, 2026.
VCBacked. (2026). Relay Therapeutics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/relay-therapeutics
{{cite web |title=Relay Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/relay-therapeutics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated